Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications
Investigative Ophthalmology & Visual Science2010Vol. 51(11), pp. 5403–5403
Citations Over TimeTop 10% of 2010 papers
Henry F. Edelhauser, Cheryl L. Rowe-Rendleman, Michael R. Robinson, Daniel G. Dawson, Gerald J. Chader, Hans E. Grossniklaus, Kay D. Rittenhouse, Clive Wilson, David A. Weber, Baruch D. Kuppermann, Karl G. Csaky, Timothy W. Olsen, Uday B. Kompella, V. Michael Holers, Gregory S. Hageman, Brian C. Gilger, Peter A. Campochiaro, Scott M. Whitcup, Wai T. Wong
Abstract
the National Institutes of Health (NIH) in Bethesda, Maryland. The conference provided an opportunity to gather a diverse group of more than 200 experts from both academic ophthalmology and the ophthalmic pharmaceutical industry, including laboratory researchers and clinicians, to discuss recent advances in delivery systems that convey ocular drugs to the posterior segment and how these systems might be successfully used in commercial products.
Related Papers
- → Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures(2005)783 cited
- → Ratiometric analysis of in vivo optical coherence tomography retinal layer thicknesses for detection of changes in Alzheimer's disease(2023)6 cited
- → Changes in retinal layer thickness with maturation in the dog: an in vivo spectral domain - optical coherence tomography imaging study(2020)12 cited
- → Retinal vascular characteristics and the strategy to manage retinal vascular diseases(2014)
- → Spectral Domain Optical Coherence Tomography correlates Retinal Thinning to Retinal Vascular Development in an In vivo Mouse Model of Retinopathy of Prematurity(2017)